Researchers at the University of Colorado Anschutz Medical Campus have uncovered a critical, previously underappreciated role ...

A new study from researchers at Moffitt Cancer Center shows that blocking a chemical process called nitrosylation could make ...

T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy ...

Scientists at Weill Cornell Medicine have uncovered a surprising new role for gut bacteria: producing bile acids that can ...

Microbiota-derived bile acids (shown in light green) blocked the androgen receptor (depicted as a door) from binding with ...

There are trillions of microbes in the gastrointestinal tract, and we are starting to learn more about the exact mechanisms ...

Tevogen's CEO, Ryan Saadi, emphasized this milestone as a significant advancement in supporting the company's pipeline of off-the-shelf, genetically unmodified CD8+ T cell therapeutics.

Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical stage biopharmaceutical company, announces it will be presenting at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting to be ...